Narayana Hrudayalaya Limited (NSE:NH)
1,742.40
-35.40 (-1.99%)
Aug 8, 2025, 2:30 PM IST
Paycor HCM Revenue
Narayana Hrudayalaya had revenue of 15.07B INR in the quarter ending June 30, 2025, with 12.40% growth. This brings the company's revenue in the last twelve months to 56.84B, up 10.89% year-over-year. In the fiscal year ending March 31, 2025, Narayana Hrudayalaya had annual revenue of 54.83B with 9.26% growth.
Revenue (ttm)
56.84B
Revenue Growth
+10.89%
P/S Ratio
6.35
Revenue / Employee
4.88M
Employees
11,659
Market Cap
361.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 54.83B | 4.65B | 9.26% |
Mar 31, 2024 | 50.18B | 4.89B | 10.79% |
Mar 31, 2023 | 45.30B | 8.28B | 22.38% |
Mar 31, 2022 | 37.01B | 11.17B | 43.24% |
Mar 31, 2021 | 25.84B | -5.53B | -17.62% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Mankind Pharma | 129.10B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 77.86B |
Aurobindo Pharma | 320.25B |
Narayana Hrudayalaya News
- 2 months ago - HSBC maintains reduce on Narayana Hrudayalaya, sees long gestation for India expansion - Business Upturn
- 2 months ago - Narayana Hrudayalaya shares rise nearly 4% after Q4 profit and revenue growth; stock nears 52-week high - Business Upturn
- 4 months ago - Narayana Hrudayalaya signs O&M agreement with Kammavari Sangham for 110-bed hospital in Bengaluru South - Business Upturn
- 5 months ago - Narayana Hrudayalaya’s subsidiary HCCI enters joint venture for cancer care in India - Business Upturn
- 6 months ago - Stocks to watch today on 21 Feb: Cipla, Senores, Narayana Hrudayalaya, Sanofi in pharmaceuticals and healthcare sector - Business Upturn
- 6 months ago - Narayana Hrudayalaya Ltd (NSE:NH) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
- 6 months ago - Key Results Today: Glenmark Pharma, ABFRL, GNFC, and Narayana Hrudayalaya among stocks in focus as Q3 results roll in - Business Upturn
- 6 months ago - Narayana Hrudayalaya shares surge 3% after lLand acquisition in South Bengaluru - Business Upturn